Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Crown Laboratories
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Crown Laboratories now operates under the name Revance, effective March 31, 2025, following its acquisition of Revance Therapeutics, Inc. This change marks a strategic transformation, uniting their science-driven brands in aesthetics and skincare to strengthen their market position and drive future growth[1][3][5].
Crown Laboratories completed the acquisition of Revance Therapeutics, Inc. on February 6, 2025, through a tender offer and subsequent second-step merger, acquiring approximately 82% of Revance's outstanding shares at $3.65 per share, delisting Revance's stock from the NASDAQ Global Select Market[2][5].
BIOJUVE® was honoured as the Best Cosmetics of the Year at the Aesthetic and Anti-Aging Medicine World Congress (AMWC) 2025 in Monaco, recognizing its innovative approach to skin biome care[1].
Open job positions at Crown Laboratories
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.

